Bac Liquid
NDC Package 81825-0013-1
Package Information
Bac (apis mellifera, arsenic trioxide, atropa belladonna, matricaria chamomilla flowering top oil, lachesis muta venom, mercurius solubilis, pulsatilla vulgaris whole, toxicodendron pubescens leaf, and silicon dioxide) liquids is adults & children above 12 years: 10 drops orally 3 times daily, or as directed by a health care professional. This formulation utilizes a liquid delivery system. Marketed by Zorex, this product is identified by NDC 81825-0013.
Identification & Billing
Clinical Specifications
- APIS MELLIFERA 30 [hp_X]/mL
- ARSENIC TRIOXIDE 30 [hp_X]/mL
- ATROPA BELLADONNA 30 [hp_X]/mL
- LACHESIS MUTA VENOM 30 [hp_X]/mL
- MATRICARIA CHAMOMILLA FLOWERING TOP OIL 30 [hp_X]/mL
- MERCURIUS SOLUBILIS 30 [hp_X]/mL
- PULSATILLA VULGARIS WHOLE 30 [hp_X]/mL
- SILICON DIOXIDE 30 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 30 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 81825 - Zorex
- 81825-0013 - Bac
- 81825-0013-1 - 30 mL in 1 BOTTLE, DROPPER
- 81825-0013 - Bac
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81825-0013-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Bac, a human over the counter drug labeled by Zorex. This liquid is formulated for oral use and contains apis mellifera; arsenic trioxide; atropa belladonna; lachesis muta venom; matricaria chamomilla flowering top oil; mercurius solubilis; pulsatilla vulgaris whole; silicon dioxide; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zorex on June 26, 2025. The current certification is valid through December 31, 2026.
How is this Zorex product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81825001301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.